Blocking TGFβ via Inhibition of the αvβ6 Integrin: A Possible Therapy for Systemic Sclerosis Interstitial Lung Disease

Interstitial lung disease (ILD) is a commonly encountered complication of systemic sclerosis (SSc) and accounts for a significant proportion of SSc-associated morbidity and mortality. Its pathogenesis remains poorly understood, and therapies that treat SSc ILD are suboptimal, at best. SSc ILD pathog...

Descripción completa

Detalles Bibliográficos
Autores principales: Katsumoto, Tamiko R., Violette, Shelia M., Sheppard, Dean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195527/
https://www.ncbi.nlm.nih.gov/pubmed/22013449
http://dx.doi.org/10.1155/2011/208219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195527/
https://www.ncbi.nlm.nih.gov/pubmed/22013449
http://dx.doi.org/10.1155/2011/208219

Ejemplares similares